128 related articles for article (PubMed ID: 3473686)
1. Teniposide (VM-26) and ara-C in the treatment of adult acute lymphoblastic leukemia.
Linker CA; Levitt LJ; O'Donnell M; Ries CA; Forman SJ
Semin Oncol; 1987 Jun; 14(2 Suppl 1):78-85. PubMed ID: 3473686
[No Abstract] [Full Text] [Related]
2. Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia.
Hoelzer D; Thiel E; Löffler H; Büchner T; Ganser A; Heil G; Kurrle E; Heimpel H; Koch P; Lipp T
Semin Oncol; 1987 Jun; 14(2 Suppl 1):92-7. PubMed ID: 3473688
[No Abstract] [Full Text] [Related]
3. Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.
Dahl GV; Rivera GK; Look AT; Hustu HO; Kalwinsky DK; Abromowitch M; Mirro J; Ochs J; Murphy SB; Dodge RK
J Clin Oncol; 1987 Jul; 5(7):1015-21. PubMed ID: 3474355
[TBL] [Abstract][Full Text] [Related]
4. [Acute lymphoblastic leukemia of high risk: results of a therapeutic protocol].
Castel V; Verdeguer A; Ferris J; Esquembre C
An Esp Pediatr; 1987 Nov; 27(5):331-4. PubMed ID: 3481522
[TBL] [Abstract][Full Text] [Related]
5. [VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults].
Marín P; Grañena A; Carreras E; Sierra J; Olivé MT; Rozman C
Sangre (Barc); 1984; 29(4-A):399-404. PubMed ID: 6594782
[No Abstract] [Full Text] [Related]
6. Intermediate and high-dose cytosine arabinoside-containing regimens for induction and consolidation therapy for patients with acute lymphoblastic leukemia and lymphoblastic non-Hodgkin's lymphoma: the Leyden experience and review of the literature.
Peters WG; Willemze R; Colly LP
Semin Oncol; 1987 Jun; 14(2 Suppl 1):86-91. PubMed ID: 3473687
[No Abstract] [Full Text] [Related]
7. VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia.
Rivera G; Dahl GV; Bowman WP; Avery TL; Wood A; Aur RJ
Cancer; 1980 Oct; 46(8):1727-30. PubMed ID: 6932995
[TBL] [Abstract][Full Text] [Related]
8. The epipodophyllotoxin teniposide in therapy for childhood acute lymphocytic leukemia.
Rivera GK
J Clin Oncol; 1988 Feb; 6(2):191-3. PubMed ID: 3276820
[No Abstract] [Full Text] [Related]
9. Teniposide and cytarabine combination chemotherapy in the treatment of relapsed adolescent and adult acute lymphoblastic leukemia.
Sanz GF; Sanz MA; Rafecas FJ; Martínez JA; Martín-Aragonés G; Marty ML
Cancer Treat Rep; 1986 Nov; 70(11):1321-3. PubMed ID: 3464352
[TBL] [Abstract][Full Text] [Related]
10. VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia.
Rivera G; Bowman WP; Murphy SB; Dahl GV; Aur RJ; Kalwinsky DK; Wood A; Stagner S; Avery TL
Med Pediatr Oncol; 1982; 10(5):439-46. PubMed ID: 6958957
[TBL] [Abstract][Full Text] [Related]
11. High-dose Ara-C plus VM-26 in adult acute lymphoblastic leukemia.
Larson RA; Gaynor ER; Shepard KV; Daly KM
Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1261-3. PubMed ID: 3865776
[No Abstract] [Full Text] [Related]
12. [Acute refractory lymphoblastic leukemia in the adult. Treatment with daunorubicin, cytosine arabinoside, 6-thioguanine, vincristine and prednisone].
Marín P; Grañena A; Carreras E; Ribera JM; Rozman C
Sangre (Barc); 1984; 29(6):987-92. PubMed ID: 6598237
[No Abstract] [Full Text] [Related]
13. Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases.
Grem JL; Hoth DF; Leyland-Jones B; King SA; Ungerleider RS; Wittes RE
J Clin Oncol; 1988 Feb; 6(2):351-79. PubMed ID: 3276827
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of acute refractory lymphoblastic leukemia in the adult with VM-26 and ARA-C].
Rafecas FJ; Sanz MA
Sangre (Barc); 1984; 29(6):1052-3. PubMed ID: 6598235
[No Abstract] [Full Text] [Related]
15. [Consolidating chemotherapy in the treatment program of acute lymphoblastic leukemia in children].
Maiakova SA; Makhonova LA
Vestn Akad Med Nauk SSSR; 1986; (5):15-7. PubMed ID: 3487897
[No Abstract] [Full Text] [Related]
16. Lymphoblastic lymphoma in adults.
Slater DE; Mertelsmann R; Koziner B; Higgins C; McKenzie S; Schauer P; Gee T; Straus D; Kempin S; Arlin Z
J Clin Oncol; 1986 Jan; 4(1):57-67. PubMed ID: 3510283
[TBL] [Abstract][Full Text] [Related]
17. Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.
Capizzi RL; Powell BL; Cooper MR; Stuart JJ; Muss HB; Richards F; Jackson DV; White DR; Spurr CL; Zekan PJ
Semin Oncol; 1985 Jun; 12(2 Suppl 3):105-13. PubMed ID: 3892697
[No Abstract] [Full Text] [Related]
18. GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukemia. Preliminary results.
Mandelli F; Annino L; Vegna ML; Camera A; Ciolli S; Deplano W; Fabiano F; Ferrara F; Ladogana S; Muti G
Leukemia; 1992; 6 Suppl 2():182-5. PubMed ID: 1578928
[No Abstract] [Full Text] [Related]
19. Risk groups in a multicenter pilot study for treatment of acute lymphoblastic and acute undifferentiated leukemia in adults.
Hoelzer D; Thiel E; Löffler H; Bodenstein H; Büchner T; Engelhardt R; Ganser A; Messerer D; Rühl H; Zwingers T
Haematol Blood Transfus; 1985; 29():48-50. PubMed ID: 3861487
[No Abstract] [Full Text] [Related]
20. Treatment of refractory acute lymphoblastic leukemia with teniposide and cytarabine.
Kamen BA; Casper J; Lauer S; Camitta BM; Holcenberg JS
Cancer Treat Rep; 1986 Jul; 70(7):935-6. PubMed ID: 3459577
[No Abstract] [Full Text] [Related]
[Next] [New Search]
